News for VBIO Stock
Vitality Biopharma Announces Effective S-1 Registration Statement and DTC Eligibility
Vitality Biopharma Enters Into $5 Million Equity Line Financing Relationship With Institutional Investor
FDA Grants Vitality Biopharma Orphan Drug Designation for VBX-100 Prodrug
Back to Sitemap